CF
NVAX icon

Centaurus Financial’s Novavax NVAX Stock Holding History

Centaurus Financial’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,029
Closed -$147K – 957
2021
Q4 		$147K Buy
1,029
+465
+82% +$79.9K 0.01% 765
2021
Q3 		$117K Buy
564
+50
+10% +$11K 0.01% 815
2021
Q2 		$109K Sell
514
-261
-34% -$47.8K 0.01% 850
2021
Q1 		$141K Sell
775
-463
-37% -$92.3K 0.01% 689
2020
Q4 		$138K Sell
1,238
-969
-44% -$103K 0.01% 651
2020
Q3 		$239K Buy
2,207
+422
+24% +$51.4K 0.03% 417
2020
Q2 		$149K Buy
+1,785
New +$68.3K 0.02% 499
2019
Q2 		– Hold
0
– -$12K – 621
2019
Q1 		– Hold
0
– – – 230
2018
Q4 		– Sell
-1
Closed -$21 – 520
2018
Q3 		$21 Sell
1
-629
-100% -$17.7K ﹤0.01% 532
2018
Q2 		$17K Sell
630
-5
-0.8% -$169 ﹤0.01% 1346
2018
Q1 		$27K Sell
635
-150
-19% -$6.03K 0.01% 454
2017
Q4 		$19K Buy
+785
New +$19.2K ﹤0.01% 320

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Centaurus Financial's NVAX Position: Q1 2022 in Review

Centaurus Financial sold out of Novavax (NVAX) in Q1 2022, closing a stake of 1,029 shares — an estimated $147K sold.

Centaurus Financial first reported a position in NVAX in Q4 2017 and held it in 11 quarters. The position peaked at $239K in Q3 2020. 381 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.

  • Centaurus Financial reported no remaining Novavax position as of Q1 2022 after selling out during the quarter.
  • Centaurus Financial sold 1,029 Novavax shares in Q1 2022, an estimated $147K.
  • Centaurus Financial first reported a position in Novavax in Q4 2017 and held it in 11 quarters.
  • Centaurus Financial's Novavax position peaked at $239K in Q3 2020.
  • 381 funds tracked by Wall St. Rank held Novavax as of Q1 2022.

Based on Centaurus Financial's 13F filing for Q1 2022, filed 13 May 2022.